Cyclophosphamide for Injection Recall: What To Do

The sunny pharmtech recall involves a sterile injectable cancer drug distributed across the United States. On August 12, 2026, the U.S. Food and Drug Administration listed recall number D-0743-2026. It covers Cyclophosphamide for Injection, USP, 1 gram per vial. The vials were manufactured by Sunny Pharmtech Inc. in Taiwan. They were made for Long Grove Pharmaceuticals, LLC of Rosemont, Illinois. The FDA classified this action as Class I. That is the agency’s most serious recall tier. In total, 4,077 units fall within the recall scope.

What the Sunny Pharmtech Recall Covers

The sunny pharmtech recall applies to one specific injectable product. It is Cyclophosphamide for Injection, USP, supplied at 1 gram per vial. Each unit is a single-dose vial. The product is Rx only, meaning prescription use only. The National Drug Code listed by the agency is NDC 81298-8112-1.

The labeling matters here. The carton and vial state “Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018.” The agency record also notes the product was manufactured in Taiwan. Sunny Pharmtech Inc. is the manufacturing firm named in the recall. Long Grove Pharmaceuticals is the distributor named on the label.

Cyclophosphamide is a chemotherapy agent. It is typically given in hospitals, infusion centers, and oncology clinics. As a result, most affected vials sit in professional inventory, not in a home medicine cabinet. However, some patients receive infusions through outpatient or home infusion services. Those patients may want to ask their care team directly.

The agency record does not publish a public lot list on the summary entry. For example, a hospital pharmacist would confirm affected stock by NDC and by checking the official notice. The agency record also does not state a retail sale date range. In most cases, the distributor and the FDA notice are the correct sources for lot-level detail.

The Hazard and Reported Injuries

The hazard in the sunny pharmtech recall is particulate matter. The FDA identified the particulate as stainless steel. Stainless steel fragments should never be present in an injectable drug. The product is delivered directly into the body, so any foreign particle bypasses the body’s normal barriers.

Particulate contamination in an injectable carries known clinical risks. Depending on particle size and location, it may cause local irritation at the injection site. It may also travel through the bloodstream. In serious scenarios, particles can contribute to vessel blockage or inflammatory reactions. That general risk profile is why the FDA treats injectable particulate as a high-priority defect.

The severity classification here is Class I. Under FDA definitions, Class I means there is a reasonable probability that use of the product will cause serious adverse health consequences or death. Typically, Class I is reserved for the most urgent defects. It is a statement about potential risk, not a finding that harm has already occurred.

Importantly, the agency record does not state whether any injuries have been reported in connection with this recall. This guide will not claim injuries occurred. It will also not claim that none occurred. Readers who received cyclophosphamide recently and had an unexpected reaction should speak with their physician.

What To Do If You Own This Product

If you hold this product, stop using it now. That applies to hospital pharmacies, oncology clinics, compounding units, and home infusion providers. Quarantine any remaining vials so they cannot be dispensed by mistake. Do not attempt to inspect a vial and clear it for use yourself. Particulate can be difficult or impossible to see reliably by eye.

Next, identify the product carefully. Check the NDC on the carton or vial for 81298-8112-1. Confirm the strength reads 1 gram per single-dose vial. Look for the “Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018” line. Sunny Pharmtech Inc. is the manufacturer named in the sunny pharmtech recall record.

For the remedy, follow the instructions in the official notice linked on this page. The agency record for this recall contains remedy text that does not appear to match the product, so this guide will not summarize it. In most cases, the official notice will explain returns, replacement, or disposal steps. Facility staff should also loop in their purchasing or drug-safety contact.

Patients have a simpler path. Do not stop cancer treatment on your own. Instead, call your oncologist or infusion center and ask whether your doses came from the recalled inventory. However, if you experienced an unusual reaction after an infusion, seek medical care promptly. You can also report the problem to the FDA MedWatch program. The official notice is here: FDA Enforcement Report — Drug Recalls

Does a Sunny Pharmtech Recall Mean You Can Sue?

A recall is not a lawsuit. That distinction matters. A recall is a safety action taken by a company, sometimes with agency oversight, to pull a product from the market. It is a correction. It is not a court finding, an admission of legal fault, or a settlement of any kind.

As a result, the sunny pharmtech recall by itself does not create a legal claim for anyone. In most product cases, a claim generally requires more than a defect notice. It typically requires an actual injury. It also requires causation, meaning evidence connecting that specific product to that specific harm. Documentation and medical records usually carry that burden.

For example, someone treated with cyclophosphamide who later had a serious, unexplained complication might have questions. Those questions are reasonable. However, chemotherapy patients often have complex medical histories and known treatment side effects. Sorting a product defect from an expected drug reaction takes qualified medical and legal review.

If you believe you were harmed, you may be eligible to pursue a claim. That is not a promise, and no outcome is guaranteed. Speak with a licensed attorney in your state who handles pharmaceutical injury matters. Bring your infusion records, vial or lot information if available, and any notes about symptoms and timing. Many attorneys review these matters at no upfront cost.

How Recalls Connect to Mass Tort Cases

Recalls do not create lawsuits, but they can become useful evidence later. A recall notice often establishes a timeline. It shows when a company learned of a defect, how it described the problem, and what it did next. In litigation, plaintiffs’ lawyers frequently use those dates to test what a manufacturer knew and when it acted.

History offers clear examples. The 2021 Philips CPAP and BiPAP recall involved sound-abatement foam that could degrade and release particles. That recall preceded consolidated federal litigation over the devices. The Takata airbag inflator recalls followed a similar path, growing into one of the largest automotive recall and litigation events on record.

Those examples do not predict anything about this product. No litigation over the sunny pharmtech recall is asserted here, and none has been verified for this guide. Typically, whether a recall ever leads to claims depends on injury reports, causation evidence, and how regulators and courts evaluate the defect over time.

For readers, the practical takeaway is documentation. Save the notice, the NDC, and your treatment records. In most cases, records created close in time are more persuasive than memory. As a result, careful record-keeping protects your options without requiring you to decide anything today.

Frequently Asked Questions

What product is affected by the sunny pharmtech recall?

It covers Cyclophosphamide for Injection, USP, 1 gram per single-dose vial, NDC 81298-8112-1. The vials were manufactured by Sunny Pharmtech Inc. in Taiwan for Long Grove Pharmaceuticals, LLC. The FDA lists 4,077 units in the recall scope.

Why is this sunny pharmtech recall labeled Class I?

Class I is the FDA’s most serious recall category. It means there is a reasonable probability that use of the product could cause serious health consequences or death. Here, the defect is stainless steel particulate matter in an injectable drug.

Have injuries been reported in the sunny pharmtech recall?

The agency record does not state whether injuries have been reported. This guide will not claim harm occurred or that it did not. If you had an unexpected reaction after treatment, contact your physician and consider reporting it to FDA MedWatch.

Were You Injured by a Recalled Product?

A recall by itself is a safety action, not a legal claim. However, if a recalled product caused a real injury, you may be eligible to pursue compensation. A licensed attorney can review your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover.

Official Sources & Resources

Verify every recall against the issuing agency before acting:

• U.S. Food and Drug Administration: official recall database — the record of truth for this notice
• CPSC: cpsc.gov — household goods, toys, furniture, appliances
• FDA: fda.gov — food, drugs, and medical devices
• NHTSA: nhtsa.gov — vehicles, tires, and child car seats
• USDA FSIS: fsis.usda.gov — meat, poultry, and egg products

Content last reviewed August 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.

Related Guides

• All Product Recalls
• All Active MDL Cases
• Mass Tort Explainers
• Mass Tort Tips
• Tort Reform by State — 50-State Comparison

Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. A product recall is a safety action by a manufacturer or regulator and does not by itself establish liability or create a legal claim. No attorney-client relationship is created by accessing or using this content. Every case is unique. If you believe you were harmed by a recalled product, consult a licensed attorney in your jurisdiction.